136 related articles for article (PubMed ID: 16424295)
21. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
22. Conventional therapy with an ACE inhibitor diminishes left ventricular dyssynchrony during the progression of heart failure.
Kurita T; Onishi K; Dohi K; Takamura T; Fujimoto N; Tanigawa T; Imanaka-Yoshida K; Wada H; Nobori T; Ito M
Int J Cardiol; 2010 Apr; 140(1):48-54. PubMed ID: 19068269
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic management of heart failure caused by systolic dysfunction.
Chavey WE; Bleske BE; Van Harrison R; Hogikyan RV; Kesterson SK; Nicklas JM
Am Fam Physician; 2008 Apr; 77(7):957-64. PubMed ID: 18441861
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
[TBL] [Abstract][Full Text] [Related]
25. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacologic treatment of chronic congestive heart failure].
Halawa B
Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
[TBL] [Abstract][Full Text] [Related]
27. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
28. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
30. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
[TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Norgard NB; Stark JE
Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
[TBL] [Abstract][Full Text] [Related]
32. Treatment of heart failure with preserved systolic function.
de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
[TBL] [Abstract][Full Text] [Related]
33. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
[TBL] [Abstract][Full Text] [Related]
34. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure.
Chinnaiyan KM; Alexander D; Maddens M; McCullough PA
Am Heart J; 2007 Feb; 153(2):189-200. PubMed ID: 17239676
[TBL] [Abstract][Full Text] [Related]
35. [Drug treatment for chronic heart failure with reduced ejection fraction].
Rickenbacher P
Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
[TBL] [Abstract][Full Text] [Related]
36. Is foxglove effective in heart failure?
Chaggar PS; Shaw SM; Williams SG
Cardiovasc Ther; 2015 Aug; 33(4):236-41. PubMed ID: 25925484
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
38. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
39. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockers and heart failure.
Cruickshank JM
Indian Heart J; 2010; 62(2):101-10. PubMed ID: 21180298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
